Food News and Research

RSS

World must 'pull together' to end hunger, stunting among children

Noting "around 170 million children under the age of five are stunted" globally, actor and UNICEF ambassador Mia Farrow writes in a CNN opinion piece, "For too long, stunting has been a silent crisis -- a personal tragedy for each family," but "the suffering of some 170 million children constitutes a global catastrophe that calls for an urgent response." Traveling with UNICEF for more than a decade, Farrow says, "Wherever there is poverty, it is the children who pay the highest price."

17 Oct 2012

Brain’s biological mechanisms may contribute to diet-related disorders

Studies released today explore the neurological component of dietary disorders, uncovering evidence that the brain's biological mechanisms may contribute to significant public health challenges - obesity, diabetes, binge eating, and the allure of the high-calorie meal. The findings were presented at Neuroscience 2012, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

17 Oct 2012

U.N. SG says eliminating discrimination, providing nutrition, health care will help women care for families

"Highlighting the role in women in producing much of the world's food and caring for the environment, [U.N.] Secretary-General Ban Ki-moon, in his message marking the International Day of Rural Women, Monday said that eliminating discrimination that prevents rural women from realizing their full potential is crucial to ending global hunger and poverty," the U.N. News Centre reports.

17 Oct 2012

FDA accepts A.P. Pharma’s resubmission of NDA for APF530

A.P. Pharma, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the Company's resubmission of its New Drug Application (NDA) for APF530.

17 Oct 2012

UAF scientists discover evolutionary origin of air breathing in vertebrates

University of Alaska Fairbanks scientists have identified what they think is the ancestral trait that allowed for the evolution of air breathing in vertebrates. They will present their research at the 42nd annual meeting of the Society for Neuroscience Oct. 17 in New Orleans.

17 Oct 2012

Mephedrone and memory loss: an interview with Craig Motbey

Mephedrone is a fairly new designer drug which has been around for a few years. It exploded in popularity in Europe (and particularly in the UK) before it started to spread in a major way elsewhere.

16 Oct 2012

Mixing mitochondrial DNA bad for physiology

Mice with mitochondrial DNA from two sources have abnormal physiology and cognition, researchers report in Cell.

16 Oct 2012

Hillenbrand enters definitive agreement to acquire Coperion

Hillenbrand, Inc. has entered into a definitive agreement to acquire privately held Coperion Capital, a portfolio company of Deutsche Beteiligungs AG, for an estimated purchase price of €408 million ($530 million at current exchange rates), which includes the assumption of an estimated €76 million of net debt and €100 million pension liability.

16 Oct 2012

FDA approves Hologic’s APTIMA HPV 16 18/45 Genotype Assay for use on TIGRIS system

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's APTIMA HPV 16 18/45 Genotype Assay for use on its TIGRIS instrument system.

From Hologic, Inc. 16 Oct 2012

First Edition: October 16, 2012

Today's early morning highlights from the major news organizations, including reports about a study regarding the possible impact of premium support on Medicare premiums.

16 Oct 2012

LRRK2 inhibitors may provide neuroprotection for patients with Parkinson's

For decades, patients with Parkinson's disease (PD) have had the same experience. Their hands start to shake uncontrollably, their limbs become rigid and they lose their balance. Years before those movement problems set in, many begin struggling with fainting, incontinence, sexual dysfunction, anxiety and depression. Many patients are still treated with a 42-year-old drug called L-DOPA, which temporarily staves off symptoms but can itself cause heart arrhythmias, stomach bleeding and hallucinations.

16 Oct 2012

Transcranial magnetic stimulation can benefit patients with depression, debilitating tinnitus

Three patients who have suffered periodic major depression throughout their adult lives told an audience attending a Loyola Grand Rounds presentation how their lives have been transformed by a new magnetic therapy.

16 Oct 2012

Fat cells need sleep to function properly: Study

In a study that challenges the long-held notion that the primary function of sleep is to give rest to the brain, researchers have found that not getting enough shut-eye has a harmful impact on fat cells, reducing by 30 percent their ability to respond to insulin, a hormone that regulates energy.

16 Oct 2012

U.S., Japan, South Korea pledge additional funds to Global Agriculture and Food Security Program

On the sidelines of the International Monetary Fund and World Bank meetings in Tokyo on Thursday, Japan and South Korea each pledged an additional $30 million over three years for the Global Agriculture and Food Security Program (GAFSP), established in 2010 to help improve food security in low-income countries, Reuters reports.

16 Oct 2012

Obesity does not affect VTE risk after knee surgery

Being morbidly obese does not increase the risk for developing venous thromboembolism after total knee arthroplasty surgery, report US researchers.

15 Oct 2012

Questions abound on compounding pharmacies after meningitis outbreak

Compounding pharmacies continue to face intense scrutiny over their drug preparation and lobbying habits after one in Massachusetts is suspected in distributing a steroid that led to a meningitis outbreak.

15 Oct 2012

Enrollment complete in Idera's IMO-3100 Phase 2 trial for psoriasis

Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.

15 Oct 2012

Maryland professor receives 2012 Distinguished Service Award from AAPS

Larry Augsburger, PhD, professor emeritus at the University of Maryland School of Pharmacy, has received the 2012 Distinguished Service Award of the American Association of Pharmaceutical Scientists (AAPS), one of the highest honors bestowed by the group of 12,000 members in more than 70 countries.

15 Oct 2012

Teagasc researchers look to seaweed for proteins with health benefits

Teagasc researchers are looking to seaweed for proteins with health benefits for use as functional foods. Historically, edible seaweeds were consumed by coastal communities across the world and today seaweed is a habitual diet in many countries, particularly in Asia.

15 Oct 2012

Database of drug-induced liver injury now available from NIH

A free source of evidence-based information for health care professionals and for researchers studying liver injury associated with prescription and over-the-counter drugs, herbals, and dietary supplements is now available from the National Institutes of Health. Researchers and health care professionals can use the LiverTox database to identify basic and clinical research questions to be answered and to chart optimal ways to diagnose and control drug-induced liver injury.

15 Oct 2012